Healthcare -
Biotechnology - NASDAQ - GB
$ 29.37
-0.71 %
$ 1.47 B
Market Cap
-28.79
P/E
Price Target
Average
146.12%
Revenue Forecast
Estimate
36.06%
EBIT
Estimate
--95.14%
Net Income
Estimate
36.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunocore Holdings plc
Wall Street analysts predict an average 1-year price target for IMCR of $72.3 , with forecasts ranging from
a
low of
$24 to a high of $100 .
IMCR Lowest Price Target
Wall Street Target
24 USD
-18.28%
IMCR Average Price Target
Wall Street Target
72.3 USD
146.12%
IMCR Highest Price Target
Wall Street Target
100 USD
240.48%
REVENUE FORECAST
Revenue Forecast Chart IMCR
EBIT FORECAST
EBIT Forecast Chart IMCR
NET INCOME FORECAST
Net Income Chart IMCR